Notably, given that MDA-MB-231 cells were more sensitive to Moracin D than in MCF-7 cells via Wnt3a/FOXM1/β-catenin signaling and activation of caspases, different signaling pathways are expected by Moracin D in two breast cancer cells. This evidence concerns the gene WNT3A and breast cancer.